Brisbane, Australia · Founded 2023 · Privately Held (backing)
Developer of biomarker-based in vitro diagnostics intended to improve detection of ovarian cancer and other women's health conditions. ProSeek Bio is based in Brisbane, Australia and was founded in 2023. Its last reported valuation was $3.9 million in Mar 2026. It has raised $1.1 million.
Last reported valuation
$3.9M
Oct 2026
Priced at
—
Total raised
$1.1M
Last round
—
No prints on record
No secondary trades in ProSeek Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ProSeek Bio with a free account
·Watch ProSeek Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ProSeek Bio stock.
